5 Questions
Which group of pSS patients has a significantly increased risk of lymphoproliferative disease?
Patients with low complement C4 levels and/or palpable purpura (Type I)
Which group of pSS patients has the most severe extraglandular manifestations?
Patients with low complement C4 levels and/or palpable purpura (Type I)
What characterizes the Type II form of pSS?
Low-risk with no increased risk of death
Which factor does NOT contribute to classifying a patient as Type I high-risk pSS?
High-grade fever in the initial stage
What distinguishes the clinical risks between Type I and Type II pSS patients?
Presence or absence of low complement C4 levels and/or palpable purpura
Learn about the two patterns of pSS that define distinct disease categories with varying clinical risks, including the high-risk disease syndrome (Type I) associated with low complement C4 levels, palpable purpura, increased risk of lymphoproliferative disease, and higher mortality rate.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
